As Ebola Spreads, Scientists Race to Find Vaccines and Treatments
The Bundibugyo virus, a little known type, previously had caused [...]
For patients with a rare cancer…
For patients with a rare cancer that arises in the [...]
After a prior misfire in…
After a prior misfire in demonstrating its protease inhibitor ensitrelvir’s [...]
HER2 combination strategies are…
HER2 combination strategies are evolving. Hear how biology and next-generation [...]
Rallybio has steered its way to a…
Rallybio has steered its way to a new reverse merger, [...]
Days after its lead clinical-stage…
Days after its lead clinical-stage asset suffered a setback, Agios [...]
Although the first-in-class…
Although the first-in-class PD-1xVEGF bispecific didn’t disappoint on its overall [...]
In its 2,000-patient Proteus…
In its 2,000-patient Proteus study, J&J tested Erleada’s benefits when [...]
Kelonia Therapeutics has shared…
Kelonia Therapeutics has shared the largest slice of data yet [...]
In the race to forge the next…
In the race to forge the next Keytruda from PD-(L)1xVEGF [...]